Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.


TSXV:AVCR - Post by User

Post by StockDoc60on Sep 30, 2020 6:30pm
224 Views
Post# 31646304

No mention of AVCR in Health ca.contract!!!!

No mention of AVCR in Health ca.contract!!!!

Government of Canada signs agreement for COVID-19 rapid tests and analyzers

September 29, 2020 - Gatineau, Quebec - Public Services and Procurement Canada

The Government of Canada is protecting the health and safety of all Canadians, while moving quickly to have access to a safe and sustainable economic recovery. This includes taking steps so Canadians can quickly and easily access COVID-19 testing.

The Honourable Anita Anand, Minister of Public Services and Procurement, and the Honourable Patty Hajdu, Minister of Health, today announced that the Government of Canada has signed an agreement with Abbott Rapid Diagnostics ULC to purchase up to 7.9 million ID NOW rapid point-of-care tests, pending Health Canada authorization of the tests.

If authorized, these tests would be deployed to provinces and territories to support them in ramping up surge capacity for COVID-19 testing.

Under the agreement with Abbott, the Government of Canada is also purchasing up to 3,800 analyzers, which are the devices that perform the test and deliver the rapid results.  

COVID-19 testing technologies are advancing as the pandemic continues. On behalf of the Public Health Agency of Canada, Public Services and Procurement Canada is actively exploring additional agreements to secure access to the most promising candidates.
------------------
 


<< Previous
Bullboard Posts
Next >>